CRIS Current Research Information System

BRIGHI, NICOLE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.064
EU - Europa 1.481
AS - Asia 635
AF - Africa 100
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.059
DE - Germania 334
GB - Regno Unito 271
IT - Italia 265
SE - Svezia 257
SG - Singapore 196
CN - Cina 184
VN - Vietnam 103
IE - Irlanda 102
IN - India 95
CH - Svizzera 51
FR - Francia 42
TG - Togo 42
BG - Bulgaria 30
CI - Costa d'Avorio 28
JO - Giordania 28
RU - Federazione Russa 28
BE - Belgio 25
ZA - Sudafrica 19
FI - Finlandia 18
EE - Estonia 16
UA - Ucraina 15
ID - Indonesia 14
NG - Nigeria 9
GR - Grecia 5
NL - Olanda 5
NI - Nicaragua 4
CL - Cile 3
ES - Italia 3
HK - Hong Kong 3
PL - Polonia 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
PH - Filippine 2
PT - Portogallo 2
TR - Turchia 2
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
MD - Moldavia 1
NO - Norvegia 1
PK - Pakistan 1
SC - Seychelles 1
Totale 4.287
Salva come PNG Salva come JPEG
Città #
Fairfield 257
Chandler 252
Southend 250
Ashburn 197
Singapore 168
Woodbridge 118
Houston 113
Seattle 112
Wilmington 112
Princeton 106
Dublin 98
Cambridge 84
Ann Arbor 62
Bern 47
Lomé 42
Bologna 41
Krefeld 41
Santa Clara 40
Berlin 35
Dong Ket 30
Sofia 30
Abidjan 28
Amman 28
Westminster 28
Beijing 22
Des Moines 21
San Diego 21
Turin 20
Brussels 17
Helsinki 16
New York 16
Bad Bellingen 15
Milan 15
Jakarta 14
Rome 14
Nanjing 12
Florence 11
Changsha 10
Padova 10
Abeokuta 9
Shenyang 9
Bühl 8
Ravenna 8
Jinan 7
Bremen 6
Chengdu 6
Hangzhou 6
Los Angeles 6
Montescudo 6
Nanchang 6
Redmond 6
Saint Petersburg 6
Torino 6
Wuhan 6
Boardman 5
Frankfurt am Main 5
Munich 5
Norwalk 5
Redwood City 5
Shanghai 5
Zhaotong 5
Dingle 4
Falls Church 4
Genoa 4
Guangzhou 4
Haikou 4
Hebei 4
Jiaxing 4
London 4
Managua 4
Medford 4
Naples 4
Cesena 3
Chicago 3
Chongqing 3
Costa Mesa 3
Dearborn 3
Fort Worth 3
Fuzhou 3
Lanzhou 3
Mountain View 3
Mülheim 3
San Francisco 3
Taiyuan 3
Thessaloniki 3
Tianjin 3
Arezzo 2
Bari 2
Boydton 2
Bucharest 2
Cinisello Balsamo 2
Dongguan 2
Empoli 2
Falkenstein 2
Gallipoli 2
Ghent 2
Hong Kong 2
Kuban 2
Lappeenranta 2
Luzzara 2
Totale 2.803
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 265
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 163
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 163
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 150
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 141
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 115
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 113
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 111
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 105
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 104
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 104
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 103
Cancer in the elderly: is it time for palliative care in geriatric oncology? 102
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 102
Severe hypernatremia as a predictor of mortality after percutaneous endoscopic gastrostomy (PEG) placement 102
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 93
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 90
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 89
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 87
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 85
Chromogranin A usefulness in small non-functioning pancreatic neuroendocrine tumors surgical management 85
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 85
Palliative care training and research: the development in europe and the bologna experience. 81
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 78
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 76
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 74
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 71
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 71
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives 70
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes 68
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 68
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis 68
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 67
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging 67
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE) 64
Cross-cultural differences in hospices. A retrospective study in Italy 61
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 60
The functioning side of the pancreas: a review on insulinomas 59
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 59
Plasma androgen receptor in prostate cancer 58
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis 54
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer 53
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 51
Cutaneous Scapular Lesion in an Elderly Woman 50
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 49
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study 47
New prognostic biomarkers in metastatic castration-resistant prostate cancer 39
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes 39
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 37
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 37
Quality of life in patients with long-standing chronic non-pathological pancreatic hyperenzymemia 36
Knife-assisted resection (KAR) for small rectal neuroendocrine neoplasia 36
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 32
Routine EUS-guided tissue acquisition in patients with resectable solid pancreatic masses - Pros and cons reassessment in 2020 32
Response 31
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis 28
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 28
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 15
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis 5
Totale 4.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020704 0 0 0 30 63 87 104 146 108 83 51 32
2020/2021518 97 20 20 45 40 15 14 23 68 32 13 131
2021/2022917 41 14 35 53 83 37 50 49 53 96 275 131
2022/20231.132 85 152 52 140 89 102 35 65 224 30 67 91
2023/2024490 26 56 28 28 20 67 9 26 167 16 21 26
2024/2025482 93 191 131 67 0 0 0 0 0 0 0 0
Totale 4.476